marsie
Lab Rat
computer programmer
Posts: 26 
|
Post by marsie on Jan 15, 2016 23:08:17 GMT -5
Matt has spread the new idea of diabetics clinic.
How can potential patients locate those clinics?
How can potential patients locate prescribing endocrinologist?
How to bring more patients into endo's office as patients?
Internet is a great medium to utilize the above?
How to do match making and help all parties?
Welcome your thoughts.
|
|
|
|
Post by coo2002coo on Jan 16, 2016 1:28:44 GMT -5
Matt has spread the new idea of diabetics clinic. How can potential patients locate those clinics? How can potential patients locate prescribing endocrinologist? How to bring more patients into endo's office as patients? Internet is a great medium to utilize the above? How to do match making and help all parties? Welcome your thoughts. The CEO said he was also optimistic about an unrelated venture by a private firm that is looking to create a diabetes care center business model that can provide in-house services to urgent care centers throughout the country. The venture, he said, is bullish on Afrezza and is planning to use the drug as its top treatment for the disorder. The first center is expected to open next month in New Jersey. “They’ve coined the term ‘real-time diabetes management, powered by Afrezza,’ ” Pfeffer said. “This is an excellent opportunity for us, and it takes no money at all from MannKind.” source from: www.newstimes.com/business/article/MannKind-announces-Afrezza-marketing-plans-6757354.php |
|
|
|
Post by mnkdmorelong on Jan 16, 2016 7:51:56 GMT -5
Matt has spread the new idea of diabetics clinic. How can potential patients locate those clinics? How can potential patients locate prescribing endocrinologist? How to bring more patients into endo's office as patients? Internet is a great medium to utilize the above? How to do match making and help all parties? Welcome your thoughts. The CEO said he was also optimistic about an unrelated venture by a private firm that is looking to create a diabetes care center business model that can provide in-house services to urgent care centers throughout the country. The venture, he said, is bullish on Afrezza and is planning to use the drug as its top treatment for the disorder. The first center is expected to open next month in New Jersey. “They’ve coined the term ‘real-time diabetes management, powered by Afrezza,’ ” Pfeffer said. “This is an excellent opportunity for us, and it takes no money at all from MannKind.” source from: www.newstimes.com/business/article/MannKind-announces-Afrezza-marketing-plans-6757354.phpUrgent care visits are emergencies. Managing diabetes is chronic. These two are not the same and will cause confusion issues. A diabetic will have to turn his back on his practice-based endo in order to place his care with these diabetic care centers. It can be done but it will take time. If these centers are successful, it will pressure the practice-based endo to revise his thinking on Afrezza. All good, but it will take time. |
|
|
|
Post by LosingMyBullishness on Jan 16, 2016 8:07:44 GMT -5
I guess some few real time diabetes care centers will be enough to create some momentum in media and at the endo's office. Such disruption especially with convincing results will get things going.
|
|
|
|
Post by LosingMyBullishness on Jan 16, 2016 8:15:24 GMT -5
Endo's are also small businesses: if they face competition they either adapt or they FUD. The latter will be difficult if the patient has met a lot of other patients at the real time centre that had great results. Suddenly the patient wonders why this doctor is so stubborn. And the lady in the centre has also much more time to talk to.
|
|
|
|
Post by mnholdem on Jan 16, 2016 8:26:49 GMT -5
I suggest that you google "India sugar clinics" to read about diabetes clinics being opened all over India. Most are connected with existing healthcare chains that specialize in family clinics and small hospitals. There's a synergy involved which makes use of existing resources. During your research, keep in mind that many countries with centralized healthcare do not have the number of specialty practices/clinics like you'll find in the U.S. so it's not uncommon for "hospital" and "clinic" to be the same thing or share the same building in most countries. Because of so many specialists in the U.S., each with his/her own clinics, advertising and referrals will be more important to the success of Diabetes Care Centers. This is where the idea may be able to capitalize on the fact that many PCP physicians send newly-diagnosed diabetics to a diabetes specialist. In the past, that meant setting up an appointment with an endocrinologist. In the future, the patient may be sent to a Diabetes Care Center. "...powered by Afrezza." |
|
|
|
Post by tripoley on Jan 16, 2016 8:31:11 GMT -5
The CEO said he was also optimistic about an unrelated venture by a private firm that is looking to create a diabetes care center business model that can provide in-house services to urgent care centers throughout the country. The venture, he said, is bullish on Afrezza and is planning to use the drug as its top treatment for the disorder. The first center is expected to open next month in New Jersey. “They’ve coined the term ‘real-time diabetes management, powered by Afrezza,’ ” Pfeffer said. “This is an excellent opportunity for us, and it takes no money at all from MannKind.” source from: www.newstimes.com/business/article/MannKind-announces-Afrezza-marketing-plans-6757354.phpUrgent care visits are emergencies. Managing diabetes is chronic. These two are not the same and will cause confusion issues. A diabetic will have to turn his back on his practice-based endo in order to place his care with these diabetic care centers. It can be done but it will take time. If these centers are successful, it will pressure the practice-based endo to revise his thinking on Afrezza. All good, but it will take time. You'd be surprised how many urgent care centers are actually providing primary care. They're convenient and you don't have to wait a few weeks to get an appointment. |
|
|
|
Post by mnkdmorelong on Jan 16, 2016 8:45:56 GMT -5
Urgent care visits are emergencies. Managing diabetes is chronic. These two are not the same and will cause confusion issues. A diabetic will have to turn his back on his practice-based endo in order to place his care with these diabetic care centers. It can be done but it will take time. If these centers are successful, it will pressure the practice-based endo to revise his thinking on Afrezza. All good, but it will take time. You'd be surprised how many urgent care centers are actually providing primary care. They're convenient and you don't have to wait a few weeks to get an appointment. I would be very surprised since insurance views urgent care as an emergency room visit. I have to believe that urgent care clinics want to remain that way. Taking on the masses reduces their ability to treat walk-in patients. The best way to go is a stand alone diabetes care center. The market is large enough. But the concept must be funded well so that current diabetics move their care over to the clinic. There is no endo in this country that will send his patient there to get better care. You must suck it out of him. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 16, 2016 8:53:20 GMT -5
I suggest that you google "India sugar clinics" to read about diabetes clinics being opened all over India. Most are connected with existing healthcare chains that specialize in family clinics and small hospitals. There's a synergy involved which makes use of existing resources. During your research, keep in mind that many countries with centralized healthcare do not have the number of specialty practices/clinics like you'll find in the U.S. so it's not uncommon for "hospital" and "clinic" to be the same thing or share the same building in most countries. Because of so many specialists in the U.S., each with his/her own clinics, advertising and referrals will be more important to the success of Diabetes Care Centers. This is where the idea may be able to capitalize on the fact that many PCP physicians send newly-diagnosed diabetics to a diabetes specialist. In the past, that meant setting up an appointment with an endocrinologist. In the future, the patient may be sent to a Diabetes Care Center. "...powered by Afrezza."Is FDA approval sufficient to market Afrezza in India? |
|
|
|
Post by peppy on Jan 16, 2016 9:35:56 GMT -5
I suggest that you google "India sugar clinics" to read about diabetes clinics being opened all over India. Most are connected with existing healthcare chains that specialize in family clinics and small hospitals. There's a synergy involved which makes use of existing resources. During your research, keep in mind that many countries with centralized healthcare do not have the number of specialty practices/clinics like you'll find in the U.S. so it's not uncommon for "hospital" and "clinic" to be the same thing or share the same building in most countries. Because of so many specialists in the U.S., each with his/her own clinics, advertising and referrals will be more important to the success of Diabetes Care Centers. This is where the idea may be able to capitalize on the fact that many PCP physicians send newly-diagnosed diabetics to a diabetes specialist. In the past, that meant setting up an appointment with an endocrinologist. In the future, the patient may be sent to a Diabetes Care Center. "...powered by Afrezza."Is FDA approval sufficient to market Afrezza in India? NEW DRUG APPROVAL PROCEDURE IN INDIA www.pharmatutor.org/articles/new-drug-approval-procedure-india
|
|
|
|
Post by mnholdem on Jan 16, 2016 10:00:18 GMT -5
Last year I read a number of ex-U.S. drug approval processes and, without even perusing peppy's link, I can state with 100% certainty that India's drug approval agency has the option of waiving the normal approval procedures for FDA-approved medicines and devices if they choose.
Later, I'll post a link to a site that lists the drug approval agencies in every country on the planet. I'll put it in the resources folder.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 16, 2016 10:06:48 GMT -5
Last year I read a number of ex-U.S. drug approval processes and, without even perusing peppy's link, I can state with 100% certainty that India's drug approval agency has the option of waiving the normal approval procedures for FDA-approved medicines and devices if they choose. Later, I'll post a link to a site that lists the drug approval agencies in every country on the planet. I'll put it in the resources folder. If it is possible to receive approval in India, MannKind should be working diligently to find a partnership for that region. |
|
nsmyth
Lab Rat
Posts: 43 
Sentiment: Long
|
Post by nsmyth on Jan 16, 2016 10:40:06 GMT -5
I suggest that you google "India sugar clinics" to read about diabetes clinics being opened all over India. Most are connected with existing healthcare chains that specialize in family clinics and small hospitals. There's a synergy involved which makes use of existing resources. During your research, keep in mind that many countries with centralized healthcare do not have the number of specialty practices/clinics like you'll find in the U.S. so it's not uncommon for "hospital" and "clinic" to be the same thing or share the same building in most countries. Because of so many specialists in the U.S., each with his/her own clinics, advertising and referrals will be more important to the success of Diabetes Care Centers. This is where the idea may be able to capitalize on the fact that many PCP physicians send newly-diagnosed diabetics to a diabetes specialist. In the past, that meant setting up an appointment with an endocrinologist. In the future, the patient may be sent to a Diabetes Care Center. "...powered by Afrezza."I looked up India Sugar Clinics and found the Apollo Clinic which has over 100 locations in India and Sanofi has taken a 20% stake in it. will that deter the clinic from featuring Afrezza (once approved in India)? I suspect it will |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 16, 2016 10:54:19 GMT -5
I suggest that you google "India sugar clinics" to read about diabetes clinics being opened all over India. Most are connected with existing healthcare chains that specialize in family clinics and small hospitals. There's a synergy involved which makes use of existing resources. During your research, keep in mind that many countries with centralized healthcare do not have the number of specialty practices/clinics like you'll find in the U.S. so it's not uncommon for "hospital" and "clinic" to be the same thing or share the same building in most countries. Because of so many specialists in the U.S., each with his/her own clinics, advertising and referrals will be more important to the success of Diabetes Care Centers. This is where the idea may be able to capitalize on the fact that many PCP physicians send newly-diagnosed diabetics to a diabetes specialist. In the past, that meant setting up an appointment with an endocrinologist. In the future, the patient may be sent to a Diabetes Care Center. "...powered by Afrezza."I looked up India Sugar Clinics and found the Apollo Clinic which has over 100 locations in India and Sanofi has taken a 20% stake in it. will that deter the clinic from featuring Afrezza (once approved in India)? I suspect it willi say not unless Afrezza was similar to injectable insulin. Afrezza is a whole different landscape and patients/doctors will embrace it .. In India patients pay for their own medicine and hence cost will be one of the factors but convenience and efficacy will not be ignored |
|
|
|
Post by daduke38 on Jan 16, 2016 10:57:33 GMT -5
I suggest that you google "India sugar clinics" to read about diabetes clinics being opened all over India. Most are connected with existing healthcare chains that specialize in family clinics and small hospitals. There's a synergy involved which makes use of existing resources. During your research, keep in mind that many countries with centralized healthcare do not have the number of specialty practices/clinics like you'll find in the U.S. so it's not uncommon for "hospital" and "clinic" to be the same thing or share the same building in most countries. Because of so many specialists in the U.S., each with his/her own clinics, advertising and referrals will be more important to the success of Diabetes Care Centers. This is where the idea may be able to capitalize on the fact that many PCP physicians send newly-diagnosed diabetics to a diabetes specialist. In the past, that meant setting up an appointment with an endocrinologist. In the future, the patient may be sent to a Diabetes Care Center. "...powered by Afrezza."I looked up India Sugar Clinics and found the Apollo Clinic which has over 100 locations in India and Sanofi has taken a 20% stake in it. will that deter the clinic from featuring Afrezza (once approved in India)? I suspect it will Probably correct. But whoever markets India eventually could give them competition. These clinics would not be expensive to build as I suggested in another post. I think SNY totally missed the bigger picture in Afrezza. JMO, but I think in the long run, getting away from SNY will be the best thing that ever happened to MNKD.
On another note, take a look at the PPS of SNY since they installed the new CEO. I know MNKD has taken more than their lumps, but SNY faces some serious challenges of their own. Tresiba will blow Toujou out of the water. |
|
